“…Apart from herpesvirus infections, other infections typically associated with immunosuppression have been described in patients treated with fingolimod, including primary cutaneous cryptococcosis [103], cryptococcal meningitis [104,105], and visceral leishmaniasis [106]. A young MS patient developed extensive molluscum contagiosum infection (around 150 lesions) [107], a phenotype that resembles that observed among HIV-infected patients with very low CD4+ T-cell counts.…”